Evidence map›Paper›PMID 31832783›Full record

ArticleMikrochimica acta2019

A molecularly imprinted polymer undergoing a color change depending on the concentration of bisphenol A.

Min Jae Shin, Jae Sup Shin

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Min Jae ShinDepartment of Cosmetics and Biotechnology, Semyung University, Jecheon, Chungbuk, 27136, South Korea.
Jae Sup ShinDepartment of Chemistry, Chungbuk National University, Cheongju, Chungbuk, 28644, South Korea. jsshin@chungbuk.ac.kr.ORCID 0000-0002-4971-697X
Chungbuk National University · KRSemyung University · KR

Funding

National Research Foundation of Korea NRF-2017R1C1B5015673National Research Foundation of Korea NRF-2017R1D1A3B03034089
6 · The paper itself

Abstract

A molecularly imprinted system is introduced here whose color gradually changes as the analyte becomes rebound. The MIP was prepared from an acryloyl-modified β-cyclodextrin (β-CD), acrylamide (AAm), and N,N'-methylenebisacrylamide (MBAA), and imprinted with bisphenol A (BPA). The sensing capability of the MIP was first tested by potentiometry. A spin-coated gold plate coated with the MIP was used as a working electrode; the electrode can differentiate BPA from phenol or p-cresol, which were used as analogs of BPA. Next, a color-responsive system was fabricated by forming a hydrogel membrane containing the modified β-CD, AAm, and MBAA. A vesicle solution was prepared from N-(2-aminoethyl)pentacosa-10,12-diynamide by sonication and incorporated into the hydrogel. The blue polydiacetylene was formed by UV photopolymerization. In the presence of BPA, this system undergoes a color change from blue to red that is proportional to the degree of BPA rebinding. The color change is due to the contraction of the gel membrane that rebinding causes. The method works to 0.5 mM BPA concentration range. The detection limits for BPA are 0.1 mM on visual assessment and 50 μM on spectrophotometric readout. Graphical AbstractA molecular imprinting system is described whose color changes from blue to red as it binds bisphenol A. The degree of rebinding can be measured by detecting the color change of polydiacetylene vesicle. CD: cyclodextrin, BPA: bisphenol A.

Indexed as

Bisphenol AColor changeCyclodextrinHydrogelMolecularly imprinted polymerMolecular recognitionPolydiacetyleneSensor

Identifiers

PMID31832783
OpenAlexW2995014549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.